Best practice guidelines for the diagnosis, evaluation, and management of cognitive disorders in Parkinson’s disease

British Geriatrics Society · 2026 · United Kingdom

Source and licence

Authors
Dana Pourzinal, Deborah Brooks, Deepa Sriram et al.
Title
Best practice guidelines for the diagnosis, evaluation, and management of cognitive disorders in Parkinson’s disease
Journal
Age and Ageing, 2026
Licence
CC BY 4.0
Changes
Verbatim excerpts; formatting adapted

Full text retrieved 2026-10-27 from Europe PMC · PMC13016819

Licence statement of the original publication

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

This page reproduces excerpts of the original publication; the original is authoritative. It has not been reviewed by a physician, does not state a recommendation of Medelix and does not replace medical advice. The guideline may have been updated since.

Open the original publication →Full text on Europe PMC

Recommendations

We found no explicitly labelled recommendations in this publication; its recommendations are in the running text of the original.

Abstract

Although cognitive impairment is prevalent in people living with Parkinson’s disease (PD), the clinical approach to cognitive disorders in PD varies significantly across health services. Here, we present updated best practice guidelines to standardise the diagnosis, evaluation, and management of cognitive disorders in PD across clinical contexts. Guideline development followed a two-phase process incorporating both expert and lived-experience perspectives. In Phase 1, preparatory research (literature reviews and a national survey) generated 58 preliminary recommendations. These were refined through a modified Delphi process with 29 clinician and research experts, resulting in 51 evidence-based and expert-endorsed recommendations. In Phase 2, perspectives of people with lived experience of cognitive disorders in PD (n = 15) were attained through focus groups, which produced 25 recommendations. A subsequent national survey (n = 81) demonstrated consensus on 24 of the 25 recommendations. Overall, the guideline development process yielded 58 unique recommendations, including recommendations for a tailored neuropsychological toolkit sensitive to cognitive decline in PD. These are the first best practice guidelines for the diagnosis, evaluation and management of cognitive disorders in PD informed by empirical evidence, expert consensus, and insights from people with lived experience. Clinical adoption of these guidelines will improve the quality of care, diagnostic accuracy, and early detection of cognitive disorders in PD. Future service models should consider incorporating these guidelines to optimise cognitive care in PD and promote evidence-based and patient-centred standards of practice.

Contents of the original publication

The section headings of the original.

  • Key Points
  • Introduction
  • Methodology
  • Phase 1: clinician and research expert consultation
  • Phase 2: lived experience expert consultation
  • Drafting of the best practice guidelines
  • Strength of recommendations
  • Intended users
  • Recommendations
  • Insights from recommendation development
  • Cognitive screening vs. comprehensive assessment
  • Making the referral
  • Making the diagnosis
  • Giving the diagnosis
  • Post-diagnostic care
  • Implementation
  • Limitations
  • Future directions
  • Conclusion
  • Contributor Information
  • Research Data Transparency and Availability:

A question about this guideline?

Medelix answers clinical questions from guidelines and studies – every statement with its source.

Are you the rights holder and object to this reproduction? Write to contact@medelix.ai and we will take the page down promptly. Imprint